Bradley & Co. Private Wealth Management, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bradley & Co. Private Wealth Management, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,920
+33.3%
1,0000.0%0.00%
+100.0%
Q2 2023$1,440
-31.4%
1,0000.0%0.00%
-50.0%
Q1 2023$2,100
+85.8%
1,0000.0%0.00%
+100.0%
Q4 2022$1,130
-43.5%
1,0000.0%0.00%
-50.0%
Q3 2022$2,000
+100.0%
1,0000.0%0.00%
+100.0%
Q2 2022$1,000
-50.0%
1,0000.0%0.00%
-50.0%
Q1 2022$2,0000.0%1,0000.0%0.00%0.0%
Q4 2021$2,000
-50.0%
1,0000.0%0.00%
-33.3%
Q3 2021$4,000
+33.3%
1,0000.0%0.00%0.0%
Q2 2021$3,000
+50.0%
1,0000.0%0.00%
+50.0%
Q1 2021$2,0001,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders